Albany, NY , Jan. 23, 2018 -- The market for brachytherapy devices is expected to clock a 4.2% CAGR from 2017 to 2022, predicts a report by Transparency Market Research. Expanding at this pace, the market is projected to attain a value of US$383.7 mn by 2022-end from US$313 mn in 2017.
Ability to Provide Precise, Highly Localized Doses Drives Demand for Brachytherapy Devices
The main USP of brachytherapy devices is that they provide accurate, highly localized doses of radiation. As a result, it steals a march over other radiation therapies that affect adjacent areas too. Brachytherapy devices are typically used in high precision treatment of small tumors, mostly found in early stages. Besides, cancer patients treated with brachytherapy devices show limited possibility of recurrence of the condition. In addition, they help to bring down both time and cost of treatment. All the aforementioned benefits of brachytherapy devices is fuelling their demand.
View Report Preview at https://www.transparencymarketresearch.com/brachytherapy-devices-market.html
“Increasing knowledge about the different advantages of brachytherapy devices among healthcare practitioners would work in favor of the market in the next few years,” explains the lead analyst of the TMR report. He adds, “In the next couple of years, the market could benefit from the swift progress in the field of image guided procedures and radiation dose delivery.” Growing range of products with 3D treatment planning technology to facilitate accurate treatment is also expected to stoke growth in the market.
Medical Tourism Benefits Market
Soaring popularity of medical tourism, in which patients travel to other regions for better or cost-effective treatment, or both, is predicted to catalyze growth in the market too, along with emergence of innovative products, namely electronic brachytherapy devices.
Request to View Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=473
The growth rate in the global market for brachytherapy devices will however be stymied on account of upcoming external radiation treatment methodologies. Concerns pertaining to procurement, storage, and handling of radiation sources are also posing a challenge to market.
In terms of techniques, the market for brachytherapy devices worldwide can be broadly split into high dose rate and low dose rate. Among them, the segment of high dose rate accounts for a dominant share in the market.
Regionally, Latin America, North America, Europe, Asia Pacific, Japan, Asia Pacific except Japan, and the Middle East and Africa are some the prominent segments that have been studied in the TMR report. Of these, North America is a leading market, which going forward will retain its position by expanding at a CAGR of 4.7% over the course of the forecast period starting from 2017 and ending in 2022.
Download PDF Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=473
The global brachytherapy devices market has numerous players operating both at the global and local level. This makes the market highly fragmented as well as competitive. To establish a stronghold in such a tough market, keen companies are leveraging multi-pronged strategies. One of them is carefully-considered collaborations to expand into new regions and harness greater resources. Such a trend is expected to make the market consolidated in the near future. Another key strategy of players is product development. They are seen increasing allocation on research and development to come up with more effective products.
Some of the prominent participants in the global market for brachytherapy devices are Varian Medical Systems, Elekta, CR Bard, Eckert and Zieglar BEBIG, and Theragenics.
Buy Brachytherapy Devices Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=473<ype=S
About TMR
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact
Nachiket Ghumare
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany, NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
Research Blog: http://theglobalhealthnews.com/


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Anta Sports Expands Global Footprint With Strategic Puma Stake
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



